Similar articles for PMID: 15195775

Year	Number of Results
1992	1
1993	3
1997	2
1998	2
1999	4
2000	1
2001	11
2002	6
2003	7
2004	7
2005	4
2006	9
2007	11
2008	4
2009	11
2010	8
2011	7
2012	7
2013	14
2014	9
2015	2
2016	1
2017	1
2018	3
2019	4
2020	1
2021	3
2022	1
2024	0

1

Rheumatoid arthritis: more aggressive approach improves outlook.

Weinblatt ME. Weinblatt ME. Cleve Clin J Med. 2004 May;71(5):409-13. doi: 10.3949/ccjm.71.5.409. Cleve Clin J Med. 2004. PMID: 15195775 Free article. Review.

2

Advances in the medical management of rheumatoid arthritis.

Scott DL. Scott DL. Hosp Med. 2002 May;63(5):294-7. doi: 10.12968/hosp.2002.63.5.2023. Hosp Med. 2002. PMID: 12066349 Review.

3

Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.

Francis S, Block MJ. Francis S, et al. Arthritis Rheum. 2010 Sep;62(9):2826; author reply 2826-8. doi: 10.1002/art.27606. Arthritis Rheum. 2010. PMID: 20556822 Free article. No abstract available.

4

Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

Kremer JM. Kremer JM. Ann Intern Med. 2001 Apr 17;134(8):695-706. doi: 10.7326/0003-4819-134-8-200104170-00013. Ann Intern Med. 2001. PMID: 11304108 Review.

5

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators. Smolen JS, et al. Lancet. 2009 Jul 18;374(9685):210-21. doi: 10.1016/S0140-6736(09)60506-7. Epub 2009 Jun 26. Lancet. 2009. PMID: 19560810 Clinical Trial.

6

Therapies for active rheumatoid arthritis after methotrexate failure.

O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E; CSP 551 RACAT Investigators. O'Dell JR, et al. N Engl J Med. 2013 Jul 25;369(4):307-18. doi: 10.1056/NEJMoa1303006. Epub 2013 Jun 11. N Engl J Med. 2013. PMID: 23755969 Free article. Clinical Trial.

7

Newer approaches to the treatment of rheumatoid arthritis.

Finesilver AG. Finesilver AG. WMJ. 2003;102(7):34-7. WMJ. 2003. PMID: 14711022 Review.

8

Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study.

Fleischmann R, Goldman JA, Leirisalo-Repo M, Zanetakis E, El-Kadi H, Kellner H, Bolce R, DeHoratius R, Wang J, Decktor D. Fleischmann R, et al. Curr Med Res Opin. 2014 Nov;30(11):2139-49. doi: 10.1185/03007995.2014.942416. Epub 2014 Jul 30. Curr Med Res Opin. 2014. PMID: 25050591 Clinical Trial.

9

Progress in the treatment of rheumatoid arthritis.

Pisetsky DS, St Clair EW. Pisetsky DS, et al. JAMA. 2001 Dec 12;286(22):2787-90. doi: 10.1001/jama.286.22.2787. JAMA. 2001. PMID: 11735734 Review. No abstract available.

10

Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.

Cacciapaglia F, Anelli MG, Rinaldi A, Serafino L, Covelli M, Scioscia C, Iannone F, Lapadula G. Cacciapaglia F, et al. Drug Dev Res. 2014 Nov;75 Suppl 1:S77-80. doi: 10.1002/ddr.21203. Drug Dev Res. 2014. PMID: 25381986 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year